Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 19, Issue 41, Pages 7055-7061Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v19.i41.7055
Keywords
IFNL3; Chronic hepatitis C; Insulin resistance; Lipids
Categories
Funding
- National Health and Medical Research Council [APP1006759]
- Robert W. Storr bequest to the Sydney Medical Foundation of the University of Sydney
- University of Sydney
Ask authors/readers for more resources
Metabolic changes are inextricably linked to chronic hepatitis C (CHC). Recently polymorphisms in the IFNL3 (IL28B) region have been shown to be strongly associated with spontaneous and treatment induced recovery from hepatitis C virus (HCV) infection. Further, circumstantial evidence suggests a link between IFNL3 single nucleotide polymorphisms and lipid metabolism, steatosis and insulin resistance in CHC. The emerging picture suggests that the responder genotypes of IFNL3 polymorphisms are associated with a higher serum lipid profile, and less frequent steatosis and insulin resistance. This review analyzes the current data regarding this interaction and its meaning for HCV pathogenesis and disease progression. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
